CRNO B
4.62 SEK
0.21 (4.86%)

Cereno Scientific will participate at the 22nd Global CVCT Forum on December 8-10 in Washington D.C., US. CVCT is a recognized and respected organization that aims to bring clinicians, patients, researchers, regulators, funders, payers, and other stakeholders together to promote the most effective cutting-edge progress in medical evidence generation and implementation.

Find more information: https://www.globalcvctforum.com/